Smoking cessation in patients with coronary artery disease
Authors:
- Mark J. EisenbergMEMark J. Eisenberg
- 1 April 2005
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 149 (4) , 565-572
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placeboClinical Therapeutics, 2001
- Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.American Journal of Public Health, 1999
- NON-NICOTINE PHARMACOTHERAPY FOR SMOKING CESSATIONPrimary Care: Clinics in Office Practice, 1999
- A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationNew England Journal of Medicine, 1999
- Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco.JACC, 1997
- The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac DiseaseNew England Journal of Medicine, 1996
- Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practiceAddiction, 1995
- Combined Use of Nicotine Patch and Gum in Smoking Cessation: A Placebo-Controlled Clinical TrialPreventive Medicine, 1995
- A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking CessationNew England Journal of Medicine, 1991
- Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham StudyAmerican Heart Journal, 1987